Mirugen
PrivateLast Round
Seed
Aug 14, 2025
Total Funding Raised
$4.55M
Company Overview
Mirugen is a biotechnology company developing gene therapy to treat blindness by reprogramming cells to unlock innate cellular repair mechanisms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mirugen Comparables
Compare Mirugen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ray Therapeutics | 78% | |
| Life Biosciences | 77% | |
| SparingVision | 76% |
Mirugen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 14, 2025 | ||||
| Grant | Dec 23, 2024 |
Key People
Founding team and executive leadership
Mirugen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CUREator | Grant |
| ANDHealth | Grant |
| Brandon Capital | Seed |
| Tin Alley Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 14, 2025
$3M round led by Brandon Capital, genesispsf, and Tin Alley Ventures.
- Dec 23, 2024
$1.27M grant round led by CUREator.
Recent news
Latest coverage and updates
- is_developingJul 16, 2026
Mirugen Pty Ltd is developing AAV-based gene therapy candidate targeting Retinitis Pigmentosa on Jul 17th '26.
Mirugen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Mirugen's valuation, stock price, and market status.
Is Mirugen a public or private company?
Mirugen is a private company.
What is the current stock price of Mirugen?
Mirugen is a private company with no public stock price. No recent secondary market data is available.
How much is Mirugen worth (valuation)?
Valuation information for Mirugen is not publicly available.
Can I buy Mirugen stock?
Mirugen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Mirugen's last funding round?
Funding round information for Mirugen is not publicly available.
Who are the main investors in Mirugen?
Investor information for Mirugen is not publicly disclosed.
Will Mirugen IPO soon?
No public IPO plans have been announced for Mirugen.
How can I track Mirugen secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Mirugen's secondary market activity and sign up for updates.